Abstract
Background:
The aim of this study was to evaluate the efficacy of ultrasonic features in predicting the malignancy of thyroid nodules in a group of Chinese patients.
Methods:
In all, 762 patients with thyroid nodules (424 malignant and 338 benign) underwent ultrasound (US) check and surgery between March 2011 and July 2014 at Peking University First Hospital were identified. Univariate and receiver operating characteristic (ROC) analyses were performed to calculate the sensitivity, specificity, negative and positive predictive values of each US feature, and the accuracy of their combinations for prediction of malignancy.
Results:
Patients with malignant nodules were younger and without obvious risk history than those in the benign group (P < 0.001, P = 0.93). No individual US sign was fully predictive of a malignant lesion. The Youden indexes of irregular margins and hypoechogenicity were the first and second highest in all US features, which were 51.9% and 45.2%, respectively. The sensitivity of solid components (89.7%) and hypoechogenicity (89.2%) and the specificity of taller-than-wide shape (98.5%) and microcalcifications (90.6%) were the first and second highest in all US features. Intranodular flow on a color Doppler examination was a weak predictor of malignancy. Under ROC analysis excepting intranodular flow, the 95% confidence interval (CI) of areas under the curves of hypoechogenicity and irregular margins with any one of the US features were overlapped that of five-feature combinations (95% CI: 0.850–0.901).
Conclusions:
We should be alert with taller-than-wide shape and microcalcifications. Intranodular flow was a weak predictor of malignancy. According to Youden indexes and ROC analysis, irregular margins and hypoechogenicity combined with solid component or taller-than-wide shapes or microcalcifications have a high predicative value for malignant thyroid nodules in Chinese patients.
Keywords: Malignancy, Thyroid Nodules, Ultrasonography
INTRODUCTION
Thyroid nodules are a common clinical finding and occur in approximately 10–70% of the general adult population and are more common in women, the elderly, and patients with a family history of thyroid disorders.[1,2,3,4,5] Malignant transformation of thyroid nodules occurs in only 5–10% of patients depending on age, gender, history of radiation exposure, and family history of cancer.[6] In a survey of ten large cities in China, the prevalence of thyroid nodules ranged from 10.2% to 18.6% and the incidence of thyroid cancer had increased from 1.78/100,000/year to 6.56/100,000/year from 1998 to 2009.[7] In this study, the incidence of thyroid nodules in 2009 was approximately 10.09/100,000 in females and 3.11/100,000 in males.[7] Moreover, thyroid ultrasounds (US) have become a popular extension of the physical examination in China, and other Asian countries such as Korea, so there was an increase in the incidence of thyroid nodules being identified as a result of the use of US. It is an essential public health concern to find an accurate and cost-effective method in China for accurate diagnosis and detection of suspicious thyroid nodules.
Thyroid US is the major diagnostic modality for the detection of thyroid nodules and has a major role in excluding the presence of malignancy.[8] Several US features such as hypoechogenicity, irregular margins, solid component, microcalcifications, taller-than-wide shape, and intranodular vascularity have been identified as major predictors of malignancy in thyroid nodules.[9,10] Although previous research agrees that these features are important for predicting malignancy risk, there is still some controversy.[11] It is well known that malignant US features can have different predictive values for the grading of the malignancy depending on nodule characteristics. Currently, there are few Chinese studies regarding the effectiveness of US in malignant thyroid nodules and no definite guideline based on Chinese evidence-based study. In this study, we analyzed the US data compared with pathology results of 762 patients who underwent surgery in our hospital. The aim of the current study was to evaluate the effectiveness of US in predicting malignant thyroid nodules.
METHODS
Study population and data collection
We consecutively enrolled patients with thyroid nodules who underwent surgery and had a pathological diagnosis between March 2011 and July 2014 at our hospital. A total of 762 patients with thyroid nodules (424 malignant and 338 benign) were included. The present study was a retrospective medical record based cohort study approved by our hospital's ethics committee. All subjects were de-identified so no need for written consent.
Thyroid gray-scale and color Doppler US LOGICOQ GRQE9 (General Electric Company, Fairfield, CT, USA) was performed. The main sonographic criteria evaluated for each nodule included the following: composition, echogenicity, taller-than-wide, margins, calcifications, and vascularity. The composition was classified as solid, cystic, or mixed. Echogenicity was classified as hyperechogenicity, isoechogenicity, and hypoechogenicity in comparison with normal thyroid tissue. The taller-than-wide shape was defined as the ratio of anteroposterior dimension to transverse dimension than 1. Nodule margins were described as well circumscribed or poorly circumscribed (irregular). Microcalcifications were defined as <2 mm. Macrocalcifications were defined as larger than 2 mm. The vascularity of each nodule on color Doppler US was classified as absent, peripheral, or central vascularity; however, when a nodule showed both peripheral and central vascularity, it was classified as having central vascularity. Each US was reanalyzed using the same classifications by one experienced sonographist.
Histological examination was paraffin wax embed after surgery and was interpreted by thyroid cytopathologists. Cytopathology was reported as benign, indeterminate (follicular or Hurthle cell neoplasm), suspicious for malignancy, or malignant according to The Bethesda System for Reporting Thyroid Cytopathology.[12]
Statistical analysis
Univariate analysis was performed to determine the risk of malignant thyroid nodules. Student's t-tests were calculated for continuous variables, such as age and tumor size. Chi-square tests and Fisher's exact test were employed for categorical variables such as gender, pathologic diagnosis, echo texture, calcification, vascularity, and margins. All tests were two-sided, and P < 0.05 was considered statistically significant. The level of discrimination was estimated using the area under the receiver operating characteristic curve (AUC). Univariate analysis and receiver operating characteristic (ROC) curve calculations were performed in SPSS 18.0 (International Bussiness Machines Corporation, Armonk, NY, USA). The Youden index was calculated using the formula (sensitivity + specificity) −1.
RESULTS
Seven hundred and sixty-two patients were enrolled in the study, of which 570 were women and 192 were men. Four hundred and twenty-four malignant thyroid carcinomas were identified, of which 410 were papillary carcinomas, 4 were follicular carcinomas, 8 were medullary carcinomas, and 2 were anaplastic carcinomas. Another 338 benign thyroid nodules were also identified. The mean age of patients in the malignant group was 45.1 ± 11.6 years, and the mean age of the benign group was 51.3 ± 11.9 years (P < 0.0001). The majority of malignant nodules was found in patients between 45–60 years (43.6%) and 18–45 years (46.5%). Only 14.4% patients had traditional risk factors. The ratio of females to males was approximately 3:1 in malignant group; however, no difference was observed in the benign group (P = 0.53) [Table 1].
Table 1.
Demographic data of patients in this study
Items | Malignancy n (%) | Benign n (%) | P |
---|---|---|---|
Number | 424 | 338 | |
Age, years, mean (SD) | 45.1 (11.6) | 51.4 (11.9) | |
<18 | 3 (0.7) | 2 (0.6) | <0.0001 |
18–<45 | 197 (46.5) | 93 (27.5) | |
45–<60 | 183 (43.2) | 163 (48.2) | |
>60 | 41 (9.7) | 80 (23.7) | |
Gender | |||
Male | 111 (26.2) | 87 (24.2) | 0.528 |
Female | 313 (73.8) | 251 (75.8) | |
Family and individual history | |||
None | 363 (85.6) | 298 (88.2) | 0.928 |
Thyroid disease | 33 (7.8) | 25 (7.4) | |
Thyroid carcinoma | 6 (1.4) | 4 (1.2) | |
Other cancer | 16 (3.8) | 8 (2.4) | |
Head and neck irradiation | 1 (0.2) | 1 (0.3) | |
Thyroid disease with thyroid carcinoma | 2 (0.5) | 1 (0.3) | |
Thyroid disease with other cancer | 1 (0.2) | 1 (0.3) | |
Thyroid carcinoma with other cancer | 2 (0.5) | 0 (0) |
SD: Standard deviation.
According to our study, no individual US sign is fully predictive of a malignant lesion. The features of US including sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value were calculated [Table 2]. The Youden indexes of irregular margins and hypoechogenicity were the first and second highest in all US features (51.9% and 45.2%, respectively). The Youden indexes of solid component, microcalcifications, and intranodular vascularity were 36.6%, 35.4%, and 14.6%, respectively. The specificity of taller-than-wide shape was 98.5%, but the Youden index was only 15.2% because of low sensitivity.
Table 2.
Diagnostic efficacy of the different US features for discrimination malignant nodules
Ultrasonic features | Carcinoma case, n (%) | Benign case, n (%) | Youden index (%) | Specificity (%) | Sensitivity (%) | PPV (%) | NPV (%) |
---|---|---|---|---|---|---|---|
Irregular margins | 306 (72.2) | 67 (19.8) | 51.9 | 79.8 | 72.1 | 82.0 | 69.1 |
Hypoechogenicity | 380 (89.6) | 147 (43.4) | 45.3 | 55.6 | 89.7 | 72.2 | 80.7 |
Solid component | 378 (89.1) | 178 (52.7) | 36.6 | 47.4 | 89.2 | 68.5 | 77.3 |
Microcalcifications | 175 (41.3) | 30 (8.9) | 35.4 | 90.6 | 44.8 | 85.8 | 56.2 |
Taller-than-wide shape | 71 (16.8) | 5 (1.5) | 15.3 | 98.5 | 16.8 | 93.4 | 48.0 |
Intranodular vascularity | 202 (47.6) | 75 (22.7) | 14.6 | 68.8 | 45.8 | 67.9 | 52.0 |
PPV: Positive predictive value; NPV: Negative predictive value; US: Ultrasound.
ROC analyses were performed on each US feature and their combinations, except intranodule flow [Figure 1]. The AUC for the combination of five US features was the largest, which was 0.876 [95% confidence interval [CI], 0.850–0.901, Table 3]. The 95% CI of AUCs of hypoechogenicity and irregular margins with anyone other feature were overlapped that of five features combinations.
Figure 1.
Comparison of receiver operating characteristic curves to evaluate the ability of different ultrasound features in predicting malignant thyroid nodules.
Table 3.
Areas under the receiver operating characteristic curve (AUC)
Items | AUC | SE | 95% CIs | |
---|---|---|---|---|
Lower limit | Upper limit | |||
Hypoechogenicity and margin and microcalcification and solid component and taller-than-wide | 0.876 | 0.013 | 0.850 | 0.901 |
Hypoechogenicity and irregular margin and microcalcification and solid component | 0.865 | 0.014 | 0.838 | 0.891 |
Hypoechogenicity and irregular margin and microcalcification | 0.849 | 0.014 | 0.821 | 0.877 |
Hypoechogenicity and irregular margin and solid component | 0.841 | 0.015 | 0.811 | 0.871 |
Hypoechogenicity and irregular margin and taller-than-wide | 0.839 | 0.015 | 0.810 | 0.867 |
Irregular margins | 0.760 | 0.018 | 0.724 | 0.795 |
Hypoechogenicity | 0.726 | 0.019 | 0.688 | 0.764 |
Solid component | 0.683 | 0.020 | 0.643 | 0.722 |
Microcalcification | 0.677 | 0.019 | 0.639 | 0.715 |
Taller-than-wide | 0.576 | 0.021 | 0.536 | 0.617 |
AUC: Areas under the receiver operating characteristic curve; SE: Standard error; CIs: Confidence intervals.
DISCUSSION
It is well accepted in the current literature that patients with a nodular thyroid should be evaluated if they meet the following criteria: male gender, preexisting autoimmune disease, history of head and neck irradiation, elderly, or have a family history of thyroid disease. Baier et al. evaluated the US data and the clinical and laboratory characteristics of 944 patients with thyroid nodules and noted an association between malignant solid component nodules and patients younger than 45 years.[13] Age is one of the criteria to evaluate malignancy in the UICC/AJCC system, which uses 45 years as the cutoff point.[14,15,16] In the current study, we found that the average age of patients with malignant nodules was 45 years without obvious risk factors and the percentage of malignant nodules among 18–45 years patients was almost as much as that among 45–60 years patients. Therefore, doctors should pay more attention to abnormal US features.
According to the 2015 American Thyroid Association Guideline Task Force, solid component hypoechoic nodules with one or more of the following features had over 70–90% risk of malignancy: irregular margins, microcalcifications, taller-than-wide shape, and rim calcifications.[17] However, in our study, irregular margins and hypoechogenicity had a higher predictive value than solid component and hypoechogenicity. For the prediction of malignancy, the sensitivity of solid component in our study was low. Azizi et al. found that solid nodules had a statistically insignificant increased risk of malignancy (73.3% of malignant and 66.0% of benign nodules were solid components; odds ratio [OR], 1.4; 95% CI, 0.9–2.3).[18] D’Souza et al. reported similar results (65.4% of cancers and 59.2% of benign nodules were solid components; OR, 1.3; 95% CI, 0.5–3.1).[19] Moon et al. found that solid components were not helpful for distinguishing malignant nodules from benign ones.[20] Solid components are not considered as good predictors of malignancy as shown by previous US studies.[21,22] Therefore, this consideration should be included in the establishment of our new guideline.
Despite the subjective variations in margin interpretation, an irregular margin is a useful marker of malignancy with high accuracy, specificity, and PPV.[23] A previous meta-analysis reported that irregular margins were a strong predictor of malignancy (OR, 7.2; specificity, 79.6%).[24] After the multivariate analysis, border irregularity as observed by US and the Bethesda IV category was able to accurately predict malignancy in 76.9% of the thyroid nodules with indeterminate cytology.[25] The present study highlights the predictive value of intranodule flow as low, which is supported by previous studies.[26,27] The limitation of our study is its retrospective design; however, this was controlled for by reevaluation of the ultrasonographic features.
In conclusion, we should be alert with taller-than-wide shape and microcalcifications. Intranodular flow was a weak predictor of malignancy. According to the Youden indexes and ROC analysis, irregular margins and hypoechogenicity combined with solid component or taller-than-wide shapes or microcalcifications have a high predicative value for malignant thyroid nodules in Chinese patients.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Footnotes
Edited by: Yi Cui
REFERENCES
- 1.Tan GH, Gharib H. Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126:226–31. doi: 10.7326/0003-4819-126-3-199702010-00009. doi: 10.7326/0003-4819-126-3-199702010-00009. [DOI] [PubMed] [Google Scholar]
- 2.Stanicic J, Prpic M, Jukic T, Boric M, Kusic Z. Thyroid nodularity – True epidemic or improved diagnostics. Acta Clin Croat. 2009;48:413–8. doi: 10.20471/acc. [PubMed] [Google Scholar]
- 3.Ruchala M, Szczepanek-Parulska E, Fularz M, Wolinski K. Risk of neoplasms in acromegaly. Contemp Oncol (Pozn) 2012;16:111–7. doi: 10.5114/wo.2012.28790. doi: 10.5114/wo.2012.28790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Przybylik-Mazurek E, Pach D, Kuzniarz-Rymarz S, Tracz-Bujnowicz M, Szafraniec K, Skalniak A, et al. Positive family history of thyroid disease as a risk factor for differentiated thyroid carcinoma. Pol Arch Med Wewn. 2011;121:441–6. [PubMed] [Google Scholar]
- 5.Kocak M, Erem C, Deger O, Topbas M, Ersoz HO, Can E. Current prevalence of goiter determined by ultrasonography and associated risk factors in a formerly iodine-deficient area of Turkey. Endocrine. 2014;47:290–8. doi: 10.1007/s12020-013-0153-2. doi: 10.1007/s12020-013-0153-2. [DOI] [PubMed] [Google Scholar]
- 6.Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive summary of recommendations. J Endocrinol Invest. 2010;33(5 Suppl):51–6. doi: 10.1007/bf03346587. [PubMed] [Google Scholar]
- 7.Sun JW, Xu XJ, Cai QM. Epidemiological Study on Thyroid Cancer in China. China Cancer. 2013;22:690–3. doi: 10.11735/j.issn.1004-0242.2013.09.A002. [Google Scholar]
- 8.Lee YH, Kim DW, In HS, Park JS, Kim SH, Eom JW, et al. Differentiation between benign and malignant solid thyroid nodules using an US classification system. Korean J Radiol. 2011;12:559–67. doi: 10.3348/kjr.2011.12.5.559. doi: 10.3348/kjr.2011.12.5.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cappelli C, Castellano M, Pirola I, Cumetti D, Agosti B, Gandossi E, et al. The predictive value of ultrasound findings in the management of thyroid nodules. QJM. 2007;100:29–35. doi: 10.1093/qjmed/hcl121. doi: 10.1093/qjmed/hcl121. [DOI] [PubMed] [Google Scholar]
- 10.Salmaslioglu A, Erbil Y, Dural C, Issever H, Kapran Y, Ozarmagan S, et al. Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules in a multinodular goiter. World J Surg. 2008;32:1948–54. doi: 10.1007/s00268-008-9600-2. doi: 10.1007/s00268-008-9600-2. [DOI] [PubMed] [Google Scholar]
- 11.Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94:1748–51. doi: 10.1210/jc.2008-1724. doi: 10.1210/jc.2008-1724. [DOI] [PubMed] [Google Scholar]
- 12.Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19:1159–65. doi: 10.1089/thy.2009.0274. doi: 10.1089/thy.2009.0274. [DOI] [PubMed] [Google Scholar]
- 13.Baier ND, Hahn PF, Gervais DA, Samir A, Halpern EF, Mueller PR, et al. Fine-needle aspiration biopsy of thyroid nodules: Experience in a cohort of 944 patients. AJR Am J Roentgenol. 2009;193:1175–9. doi: 10.2214/AJR.08.1840. doi: 10.2214/ajr.08.1840. [DOI] [PubMed] [Google Scholar]
- 14.Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, et al. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: A prospective study. J Clin Endocrinol Metab. 2012;97:2354–61. doi: 10.1210/jc.2011-3494. doi: 10.1210/jc.2011-3494. [DOI] [PubMed] [Google Scholar]
- 15.Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB. Indeterminate fine-needle aspiration biopsy of the thyroid: Identification of subgroups at high risk for invasive carcinoma. Surgery. 1994;116:1054–60. [PubMed] [Google Scholar]
- 16.Carpi A, Ferrari E, Toni MG, Sagripanti A, Nicolini A, Di Coscio G. Needle aspiration techniques in preoperative selection of patients with thyroid nodules: A long-term study. J Clin Oncol. 1996;14:1704–12. doi: 10.1200/JCO.1996.14.5.1704. [DOI] [PubMed] [Google Scholar]
- 17.Haugen BR, Alexander EK, Bible KC, Doherty G, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015:1–411. doi: 10.1089/thy.2015.0020. doi: 10.1089/thy.2015.0020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Azizi G, Keller J, Lewis M, Puett D, Rivenbark K, Malchoff C. Performance of elastography for the evaluation of thyroid nodules: A prospective study. Thyroid. 2013;23:734–40. doi: 10.1089/thy.2012.0227. doi: 10.1089/thy.2012.0227. [DOI] [PubMed] [Google Scholar]
- 19.D'Souza MM, Marwaha RK, Sharma R, Jaimini A, Thomas S, Singh D, et al. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography. Ann Nucl Med. 2010;24:345–55. doi: 10.1007/s12149-010-0357-y. doi: 10.1007/s12149-010-0357-y. [DOI] [PubMed] [Google Scholar]
- 20.Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, et al. Benign and malignant thyroid nodules: US differentiation – Multicenter retrospective study. Radiology. 2008;247:762–70. doi: 10.1148/radiol.2473070944. doi: 10.1148/radiol.2473070944. [DOI] [PubMed] [Google Scholar]
- 21.Lew JI, Rodgers SE, Solorzano CC. Developments in the use of ultrasound for thyroid cancer. Curr Opin Oncol. 2010;22:11–6. doi: 10.1097/CCO.0b013e3283337f16. doi: 10.1097/cco.0b013e3283337f16. [DOI] [PubMed] [Google Scholar]
- 22.Kim KM, Park JB, Kang SJ, Bae KS. Ultrasonographic guideline for thyroid nodules cytology: Single institute experience. J Korean Surg Soc. 2013;84:73–9. doi: 10.4174/jkss.2013.84.2.73. doi: 10.4174/jkss.2013.84.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Seo H, Na DG, Kim JH, Kim KW, Yoon JW. Ultrasound-based risk stratification for malignancy in thyroid nodules: A four-tier categorization system. Eur Radiol. 2015;25:2153–62. doi: 10.1007/s00330-015-3621-7. doi: 10.1007/s00330-015-3621-7. [DOI] [PubMed] [Google Scholar]
- 24.Wolinski K, Szkudlarek M, Szczepanek-Parulska E, Ruchala M. Usefulness of different ultrasound features of malignancy in predicting the type of thyroid lesions: A meta-analysis of prospective studies. Pol Arch Med Wewn. 2014;124:97–104. doi: 10.20452/pamw.2132. [DOI] [PubMed] [Google Scholar]
- 25.González-González A, Mate Valdezate A, Parra Arroyo A, Tenías Burillo JM. Diagnostic efficiency of sonographic findings of thyroid nodules in the detection of malignancy. Endocrinol Nutr. 2010;57:240–4. doi: 10.1016/j.endonu.2010.03.006. [DOI] [PubMed] [Google Scholar]
- 26.Cantisani V, Catania A, De Antoni E, Greco R, Caruso R, Di Segni M, et al. Is pattern III as evidenced by US color-Doppler useful in predicting thyroid nodule malignancy? Large-scale retrospective analysis. Clin Ter. 2010;161:e49–52. [PubMed] [Google Scholar]
- 27.Moon HJ, Kwak JY, Kim MJ, Son EJ, Kim EK. Can vascularity at power Doppler US help predict thyroid malignancy? Radiology. 2010;255:260–9. doi: 10.1148/radiol.09091284. doi: 10.1148/radiol.09091284. [DOI] [PubMed] [Google Scholar]